Against Malaria Foundation: What Donors Should Know in 2026

Against Malaria Foundation occupies an unusual position in the charity landscape. It is simultaneously one of the most rigorously evaluated nonprofits in the world and one of the least well-known outside of effective altruism circles. For donors who make decisions based on evidence rather than emotion, it is worth understanding in detail.

What AMF does

Against Malaria Foundation funds the distribution of long-lasting insecticidal nets — bed nets treated with insecticide that protect sleeping people from malaria-carrying mosquitoes. That is essentially the entire scope of its work. No programs, no staff in the field, no community development components. It raises money, purchases nets, ships them to partner organizations in sub-Saharan Africa, and monitors distribution and usage.

This narrow focus is deliberate and is the source of both its strength and its limitations as an organization.

Why GiveWell recommends it

GiveWell has recommended AMF as a top charity for over a decade, which is unusual longevity in a space where recommendations change frequently. The recommendation is based on cost-effectiveness analysis: malaria kills hundreds of thousands of people annually, mostly children under five, and bed nets are one of the most cost-effective interventions known to reduce malaria mortality. AMF's operational model — direct procurement, third-party distribution partners, post-distribution monitoring surveys — allows GiveWell to estimate cost per life saved with more precision than almost any other intervention.

The current estimate puts cost per life saved in the range of several thousand dollars, which compares favorably to most health interventions in high-income countries and extremely favorably to most charitable giving categories.

The monitoring model

AMF requires its distribution partners to conduct post-distribution monitoring surveys confirming that nets reached intended recipients and are being used. These surveys are conducted by independent parties and results are published on AMF's website. This is a genuine accountability mechanism that most organizations do not have.

Where the criticism comes from

Two areas generate legitimate questions about AMF. First, the narrow focus means AMF does not address the broader determinants of malaria burden — poverty, healthcare infrastructure, water management. Donors who want to support systemic change rather than targeted intervention may find AMF's model unsatisfying even if the cost-effectiveness numbers are strong.

Second, scale questions. AMF has grown significantly as effective altruism communities have directed funding toward it. Some researchers have questioned whether the specific net distribution model maintains the same effectiveness at very large scale or whether diminishing returns apply. AMF and GiveWell have addressed these concerns in published analyses, but the debate is ongoing.

What donors should know

AMF is among the most transparent, rigorously evaluated, and evidence-backed charitable organizations operating today. If your goal is to save lives per dollar donated with high confidence in the evidence base, it belongs at the top of your consideration set. If your goal is supporting work in your local community or addressing causes beyond infectious disease, other organizations will serve that goal better.